Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

A male patient developed frontal fibrosing alopecia after antiandrogen therapy for prostate cancer.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Finasteride may help treat frontal fibrosing alopecia, but more research is needed.

COX-2 and Bcl-2 proteins are involved in Lichen Planus.

The CRH/CRH-R1 system might be involved in causing lichen planus.

Patients with lichen planus should be tested for hepatitis C.

Benign skin tumors need accurate diagnosis to ensure proper treatment.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Isotretinoin was not effective in treating facial lichen planopilaris.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.